PharmaResearch Co., Ltd.
KOE: 214450.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Sang-Soo Jung
- Employees
- 408
- Headquarters
- Seongnam-si, South Korea
- IPO year
- 2015
- Market cap
- ₩3.5T
- Website
- http://www.pharmaresearch.co.kr
Loading 214450…
Loading profile data…Frequently asked questions about 214450
What does PharmaResearch Co., Ltd. (214450.KQ) do?
PharmaResearch Co., Ltd. operates as a biopharmaceutical company in South Korea. The company offers Re-An eye drops for protecting eyes from corneal damages with various causes; Rejuvenex injection, a tissue regeneration activator that regenerates connective tissues, including ligament, tendon, skin, etc.; Rejuvenex cream, which treats the wound...
Where does 214450.KQ trade?
PharmaResearch Co., Ltd. (214450.KQ) trades on the KOSDAQ.
What sector is 214450.KQ in?
PharmaResearch Co., Ltd. (214450.KQ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of PharmaResearch Co., Ltd.?
Sang-Soo Jung is the chief executive officer of PharmaResearch Co., Ltd. (214450.KQ).
Where is PharmaResearch Co., Ltd. headquartered?
PharmaResearch Co., Ltd. is headquartered in South Korea.
Does 214450.KQ pay a dividend?
Yes — PharmaResearch Co., Ltd. (214450.KQ) paid a trailing twelve-month dividend of KRW 1100.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 214450.KQ go public?
PharmaResearch Co., Ltd. (214450.KQ) completed its initial public offering in 2015.